World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00621829
Date of registration: 12/02/2008
Primary sponsor: University of California, Davis
Public title: Fish Oil to Prevent Asthma Exacerbations in Patients With ALOX5 Polymorphisms
Scientific title: Pilot Study of Supplemental Eicosapentanoic Acid (EPA)-Enriched Omega-3 Polyunsaturated Fatty Acids (n3-PUFA) in a Subset of Moderate to Severe Asthmatics With Polymorphisms of the Arachidonate 5-lipoxygenase (ALOX5) Gene
Date of first enrolment: February 2008
Target sample size: 30
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00621829
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment  
Countries of recruitment
United States
Contacts
Name:   Nicholas Kenyon, MD
Address: 
Telephone:
Email:
Affiliation:  University of California, Davis
Name:   Charles Stephensen, Ph.D.
Address: 
Telephone:
Email:
Affiliation:  USDA, Staff Scientist
Key inclusion & exclusion criteria

Inclusion Criteria:

- Children and adults patients >18 years or older with moderate and severe asthma (as
diagnosed by lung specialist physician), based on the NIH NAEPP 1997 guidelines, who
do not have an acute exacerbation at the time of enrollment and are on the same
asthma medications for at least 1 month

Exclusion Criteria:

- Less than 18 years of age

- Baseline FEV1 < 35% predicted

- Known or suspected allergy to fish oil products

- Pregnant women and nursing women

- Current smokers or subjects with a 20 pack-year history of smoking



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
Asthma
Intervention(s)
Dietary Supplement: EPA enriched fish oils
Primary Outcome(s)
Asthma exacerbations [Time Frame: 3 months]
Secondary Outcome(s)
Secondary ID(s)
CHNR07702
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
National Institutes of Health (NIH)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history